The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
The US drug regulator has missed a deadline for granting full approval to Novavax's Covid-19 vaccine, the company said on ...
The U.S. Food and Drug Administration has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...